Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MJFF grant supports Asceneuron's preclinical evaluation of ASN-51 for Parkinson's disease

May 4, 2022

PRISM BioLab discovers Notch signaling inhibitors

May 4, 2022

Lilly patents dopamine D1 receptor positive allosteric modulators

May 3, 2022

Curome Biosciences presents new quinone derivatives

May 2, 2022

ProMIS reports potential therapeutic approaches for ALS and nominates lead candidate

April 29, 2022

Discovery of novel D4R antagonist with favorable in vivo PK profile

April 29, 2022

AC-0027875, a gamma-secretase modulator for the treatment of AD

April 29, 2022

University of California discloses new PRMT8 inhibitors

April 29, 2022

Study finds targets of T-cell response in multiple sclerosis

April 28, 2022

Herantis reports blood-brain barrier penetration data with HER-096 in dogs

April 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...